Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
| [0060]
|
Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses
| [0060]
|
J. Biomed. Mater. Res.
| [0077]
|
J. Biomed. Mater. Res.
| [0077]
|
J. Biomed. Mater. Res.
| [0077]
|
Orthop. Res.
| [0077]
|
Culture of Animal Cells: A Manual of Basic Technique
| [0097]
|
Human Gene Therapy
| [0101]
|
Calcif. Tissue Int.
| [0101]
|
Nat. Med.
| [0103]
|
Molecular Cloning A Laboratory Manual
| [0182]
|
DNA Cloning
| [0182]
|
Oligonucleotide Synthesis
| [0182]
|
Nucleic Acid Hybridization
| [0182]
|
Transcription And Translation
| [0182]
|
Culture Of Animal Cells
| [0182]
|
Immobilized Cells And Enzymes
| [0182]
|
A Practical Guide To Molecular Cloning
| [0182]
|
Methods In Enzymology
| [0182]
|
Gene Transfer Vectors For Mammalian Cells
| [0182]
|
Immunochemical Methods In Cell And Molecular Biology
| [0182]
|
Handbook Of Experimental Immunology
| [0182]
|
Manipulating the Mouse Embryo
| [0182]
|
American Gastroenterological Association Medical Position Statement: Perianal Crohn's Disease
| [0183]
|
Inflamm Bowel Dis
| [0183]
|
Acta Gastroenterol Belg
| [0183]
|
Eur J Surg
| [0183]
|
Plastic Reconstr Surg
| [0183]
|
Tissue Eng
| [0183]
|
Int J Colorectal Dis
| [0183]
|
New Engl J Med
| [0183]
|
Lancet
| [0183]
|
Nat Biotechnol.
| [0183]
|
New Eng J Med
| [0183]
|
Science
| [0183]
|
Annu. Rev. Cell Dev. Biol.
| [0183]
|
Science
| [0183]
|
Curr Top Microbiol Immunol.
| [0183]
|
Science
| [0183]
|
Cells Tissues Organs
| [0183]
|
Exp Hematol.
| [0183]
|
Orthop Res.
| [0183]
|
Science
| [0183]
|
J Cell Sci.
| [0183]
|
Clin Orthop.
| [0183]
|
Muscle Nerve
| [0183]
|
Bone.
| [0183]
|
Exp Neurol.
| [0183]
|
Am Surg.
| [0183]
|
Exp Hematol
| [0183]
|
Trends Mol Med.
| [0183]
|
J Biol Chem
| [0183]
|
Crohn's disease. Lancet
| [0184]
|
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
| [0184]
|
The spectrum of perianal Crohn's disease in a population-based cohort
| [0184]
|
Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease
| [0184]
|
Pathophysiology of fistula formation in Crohn's disease
| [0184]
|
Diagnosis and management of fistulizing Crohn's disease
| [0184]
|
The clinical course of fistulating Crohn's disease
| [0184]
|
Infliximab maintenance therapy for fistulizing Crohn's disease
| [0184]
|
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study
| [0184]
|
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study
| [0184]
|
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
| [0184]
|
Infliximab for the treatment of fistulas in patients with Crohn's disease
| [0184]
|
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
| [0184]
|
6-Mercaptopurine is effective in Crohn's disease without concomitant steroids
| [0184]
|
Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease
| [0184]
|
Metronidazole therapy for perineal Crohn's disease: a follow-up study
| [0184]
|
Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease
| [0184]
|
Disappointing durable remission rates in complex Crohn's disease fistula
| [0184]
|
Fistulizing Crohn's disease: Diagnosis and management
| [0184]
|
Mesenchymal stem cells: mechanisms of inflammation
| [0184]
|
Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases
| [0184]
|
Recurrent anal fistulae: limited surgery supported by stem cells
| [0184]
|
Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
| [0184]
|
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
| [0184]
|
Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group
| [0184]
|
A new measure of health status for clinical trials in inflammatory bowel disease
| [0184]
|
Adalimumab for the treatment of fistulas in patients with Crohn's disease
| [0184]
|
A sharper Bonferroni procedure for multiple tests of significance
| [0184]
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
| [0184]
|
Review article: The medical treatment of Crohn's perianal fistulas
| [0184]
|
American Gastroenterological Association medical position statement: perianal Crohn's disease
| [0184]
|
Recent developments in the surgical management of perianal fistula for Crohn's disease
| [0184]
|